Skip Navigation

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Breteler, M. M.
Right arrow Articles by Mortimer, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Breteler, M. M.
Right arrow Articles by Mortimer, J. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Journal of Epidemiology, Vol 20, S36-S42, Copyright © 1991 by International Epidemiological Association

ARTICLES

Medical history and the risk of Alzheimer's disease: a collaborative re- analysis of case-control studies. EURODEM Risk Factors Research Group

MM Breteler, CM van Duijn, V Chandra, L Fratiglioni, AB Graves, A Heyman, AF Jorm, E Kokmen, K Kondo and JA Mortimer
Department of Epidemiology and Biostatistics, Erasmus University Medical School, Rotterdam, The Netherlands.

In a re-analysis of eight case-control studies on Alzheimer's disease we explored several medical conditions that had previously been suggested as possible risk factors for Alzheimer's disease. History of hypothyroidism was increased in cases as compared to controls (relative risk 2.3; 95% confidence interval 1.0-5.4). Severe headaches and migraine were inversely related to Alzheimer's disease (relative risk 0.7; 95% confidence interval 0.5-1.0). More cases than controls reported epilepsy before onset of Alzheimer's disease (relative risk 1.6; 95% confidence interval 0.7-3.5), especially for epilepsy with an onset within 10 years of onset of dementia. Neurotropic viruses, allergic conditions, general anaesthesia and blood transfusions were not associated with Alzheimer's disease.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Neurosci.Home page
E. Planel, K. E. G. Richter, C. E. Nolan, J. E. Finley, L. Liu, Y. Wen, P. Krishnamurthy, M. Herman, L. Wang, J. B. Schachter, et al.
Anesthesia Leads to Tau Hyperphosphorylation through Inhibition of Phosphatase Activity by Hypothermia
J. Neurosci., March 21, 2007; 27(12): 3090 - 3097.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
V. Fodale, D. Quattrone, C. Trecroci, V. Caminiti, and L. B. Santamaria
Alzheimer's disease and anaesthesia: implications for the central cholinergic system
Br. J. Anaesth., October 1, 2006; 97(4): 445 - 452.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
P. P. Zandi, J. C. Anthony, K. M. Hayden, K. Mehta, L. Mayer, and J. C.S. Breitner
Reduced incidence of AD with NSAID but not H2 receptor antagonists: The Cache County Study
Neurology, September 24, 2002; 59(6): 880 - 886.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
S. Volpato, J. M. Guralnik, L. P. Fried, A. T. Remaley, A. R. Cappola, and L. J. Launer
Serum thyroxine level and cognitive decline in euthyroid older women
Neurology, April 9, 2002; 58(7): 1055 - 1061.
[Abstract] [Full Text] [PDF]

Home page
 Int J EpidemiolHome page
S. L Tyas, J. Manfreda, L. A Strain, and P. R Montgomery
Risk factors for Alzheimer's disease: a population-based, longitudinal study in Manitoba, Canada
Int. J. Epidemiol., June 1, 2001; 30(3): 590 - 597.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.